全文获取类型
收费全文 | 3275篇 |
免费 | 143篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 147篇 |
妇产科学 | 69篇 |
基础医学 | 322篇 |
口腔科学 | 83篇 |
临床医学 | 238篇 |
内科学 | 839篇 |
皮肤病学 | 68篇 |
神经病学 | 319篇 |
特种医学 | 304篇 |
外科学 | 366篇 |
综合类 | 80篇 |
预防医学 | 161篇 |
眼科学 | 50篇 |
药学 | 145篇 |
中国医学 | 9篇 |
肿瘤学 | 211篇 |
出版年
2023年 | 12篇 |
2022年 | 21篇 |
2021年 | 55篇 |
2020年 | 25篇 |
2019年 | 34篇 |
2018年 | 44篇 |
2017年 | 42篇 |
2016年 | 45篇 |
2015年 | 60篇 |
2014年 | 110篇 |
2013年 | 155篇 |
2012年 | 162篇 |
2011年 | 143篇 |
2010年 | 105篇 |
2009年 | 130篇 |
2008年 | 144篇 |
2007年 | 154篇 |
2006年 | 133篇 |
2005年 | 130篇 |
2004年 | 118篇 |
2003年 | 100篇 |
2002年 | 104篇 |
2001年 | 74篇 |
2000年 | 103篇 |
1999年 | 65篇 |
1998年 | 100篇 |
1997年 | 61篇 |
1996年 | 84篇 |
1995年 | 58篇 |
1994年 | 57篇 |
1993年 | 53篇 |
1992年 | 46篇 |
1991年 | 57篇 |
1990年 | 51篇 |
1989年 | 70篇 |
1988年 | 53篇 |
1987年 | 47篇 |
1986年 | 58篇 |
1985年 | 54篇 |
1984年 | 37篇 |
1983年 | 31篇 |
1982年 | 17篇 |
1981年 | 22篇 |
1980年 | 22篇 |
1979年 | 22篇 |
1978年 | 18篇 |
1977年 | 23篇 |
1975年 | 18篇 |
1970年 | 15篇 |
1967年 | 10篇 |
排序方式: 共有3433条查询结果,搜索用时 15 毫秒
101.
CA Tan D. del Gaudio M.A. Dempsey K. Arndt S. Botes A. Reeder S. Das 《Clinical genetics》2014,85(4):353-358
Primary Autosomal Recessive Microcephaly (MCPH) is characterized by congenital microcephaly usually without additional clinical findings. The most common gene implicated in MCPH is ASPM and a large percentage of mutations described have been homozygous and in consanguineous families primarily of East Asian and Middle Eastern origin. ASPM sequencing was performed on 400 patients between the years 2009 and 2012. Seventy of the patient samples were also analyzed for copy number changes in the ASPM gene. Forty protein truncating mutations, including 29 novel mutations, were identified in 39 patients with MCPH. Approximately one third of patients were compound heterozygotes, indicative of non‐consanguinity in these patients. In addition, 46 non‐synonymous variants were identified and interpreted as variants of uncertain significance. No deletion/duplication in ASPM was identified in the patients analyzed. A wide ethnic distribution was observed, including the first reported patients with ASPM‐related MCPH of Hispanic descent. Clinical information was collected for 26 of the ASPM‐positive patients and 41 of the ASPM‐negative patients. As more individuals are identified with MCPH, we anticipate that we will continue to identify ASPM mutation‐positive patients from all ethnic origins supporting the occurrence of this genetic condition beyond that of consanguineous families of certain ethnic populations. 相似文献
102.
103.
104.
Flora Maria Lorenzo Fortes Ney Boa Sorte Victor D Mariano La la D Andrade Fernanda A Oliveira Monique CA Santos Cl udia Ivanilda N dos Santos Catharina A Passos Mila P Pacheco Valdiana C Surlo Neog lia P de Almeida Jaciane AM Fontes r a M Pimentel Raquel Rocha Genoile Oliveira Santana 《World journal of gastroenterology : WJG》2020,26(44):6993-7004
BACKGROUNDThere has been an increase in cases of inflammatory bowel disease (IBD) in recent years. There is also greater access and availability of immunosuppressive and biological agents, which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing. Tuberculosis (TB) remains a public health problem, and it has a high incidence in several countries. Therefore, knowledge of the risk of developing TB in patients with IBD is important.AIMTo evaluate the risk of active TB in patients with IBD under treatment from an endemic area in Latin America.METHODSA standard questionnaire included demographic variables, clinical aspects of IBD disease, history of active TB during treatment, active TB characteristics and evolution, initial screening and results and time from the start of anti-tumor necrosis factor alpha (TNFα) to TB development.RESULTSAzathioprine, anti-TNFα and the combination of these two drugs were associated with a higher risk of active TB incidence. The TNFα blockers increased the relative risk of developing active TB compared to other treatments. All four multivariable models showed that the use of TNFα blockers alone or in combination with azathioprine was an important risk factor for the incidence of active TB. After adjustment for sex, age, type of IBD and latent TB, anti-TNFα with azathioprine increased the relative risk to 17.8 times more than conventional treatment. Late TB, which was diagnosed 3 mo after the start of anti-TNFα, was the most frequent.CONCLUSIONTreatment with anti-TNFα increased the risk of active TB in IBD patients from an endemic area in Latin America. This risk was increased when anti-TNFα was combined with azathioprine. The time from the beginning of the treatment to the active TB diagnosis suggests a new TB infection. 相似文献
105.
106.
107.
108.
109.
110.
Leung AA Keohane C Amato M Simon SR Coffey M Kaufman N Cadet B Schiff G Zimlichman E Seger DL Yoon C Song P Bates DW 《Journal of general internal medicine》2012,27(7):801-807